Document Detail

TLI in refractory chronic GVHD.
MedLine Citation:
PMID:  23222383     Owner:  NLM     Status:  Publisher    
Refractory chronic GVHD (cGVHD) remains a major cause of morbidity after transplantation. Many drugs are used but there is no consensus on the standard of care. We investigated the efficacy of TLI in corticosteroid-refractory cGVHD. We analyzed retrospectively 31 patients receiving one or more TLI session for refractory cGVHD from 2000 to 2007. The main objective was to evaluate the response rate after TLI. Decreased corticosteroid doses and/or discontinued immunosuppressive agents were considered to be surrogate markers of response. All but one patient presented with severe cGVHD at the time of TLI. The median number of previous immunosuppressive treatment lines was 3 (range: 2-4). Fourteen patients (45%) achieved an objective response after TLI and 8 (25%) were cGVHD free at long-term follow-up. In all, 5 (29%) of the 17 nonresponsive patients did not show the features of progressive cGVHD and could decrease the amount of immunosuppressive drugs taken. Response after TLI significantly improved 5-year GVHD-related mortality (14% vs 42%, P=0.038) but not OS (58%vs 64% P=0.27). Regarding the promising response rate in this heavily pretreated population, we reasoned that TLI could be an alternative treatment for corticosteroid-refractory cGVHD.Bone Marrow Transplantation advance online publication, 10 December 2012; doi:10.1038/bmt.2012.240.
R Devillier; L Castagna; L Gonzague; J E L Cheikh; S Fürst; C Faucher; R Michel; D Blaise
Related Documents :
8909663 - A randomized double-blinded comparison of metoclopramide, ondansetron and cyclizine in ...
23993323 - Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents ...
23793413 - Two-micron thulium laser resection of the distal ureter and bladder cuff during nephrou...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-10
Journal Detail:
Title:  Bone marrow transplantation     Volume:  -     ISSN:  1476-5365     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1] Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France [2] Aix-Marseille Université, Marseille, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of spleen status on early outcomes after hematopoietic cell transplantation.
Next Document:  Graft failure in the modern era of allogeneic hematopoietic SCT.